[HTML][HTML] Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
Background Many commonly used drugs were evaluated as repurposed treatment options
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
A Khalaji, AH Behnoush… - Lipids in Health …, 2023 - research-repository.uwa.edu.au
Background: Many commonly used drugs were evaluated as repurposed treatment options
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials.
A Khalaji, AH Behnoush, S Alilou… - Lipids in Health & …, 2023 - search.ebscohost.com
Background: Many commonly used drugs were evaluated as repurposed treatment options
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
A Khalaji, AH Behnoush, S Alilou… - Lipids in Health and …, 2023 - search.proquest.com
Background Many commonly used drugs were evaluated as repurposed treatment options
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
[PDF][PDF] Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
A Khalaji, AH Behnoush, S Alilou, M Rezaee, S Peiman… - 2023 - researchgate.net
Background Many commonly used drugs were evaluated as repurposed treatment options
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials.
A Khalaji, AH Behnoush, S Alilou… - Lipids in Health and …, 2023 - europepmc.org
Background Many commonly used drugs were evaluated as repurposed treatment options
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
A Khalaji, AH Behnoush, S Alilou… - Lipids in health …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Many commonly used drugs were evaluated as repurposed treatment options
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
[HTML][HTML] Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
A Khalaji, AH Behnoush, S Alilou… - Lipids in Health and …, 2023 - ncbi.nlm.nih.gov
Background Many commonly used drugs were evaluated as repurposed treatment options
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
[HTML][HTML] Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
A Khalaji, AH Behnoush, S Alilou… - Lipids in Health …, 2023 - lipidworld.biomedcentral.com
Many commonly used drugs were evaluated as repurposed treatment options since the
emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has been …
emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has been …
[PDF][PDF] Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
A Khalaji, AH Behnoush, S Alilou, M Rezaee, S Peiman… - 2023 - scienceopen.com
Background Many commonly used drugs were evaluated as repurposed treatment options
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …
since the emergence of the COVID-19 pandemic. The benefit of lipid-lowering agents has …